Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1141 ARTÍCULOS , VIENDO DEL 946 AL 960

Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease

Li C, Ebrahimi A, Schluesener H.

Ageing Res Rev. 2013 Jan;12(1):116-40. doi: 10.1016/j.arr.2012.09.002. Epub 2012 Sep 12.

Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis

Maulik M, Westaway D, Jhamandas JH, Kar S.

Mol Neurobiol. 2013 Feb;47(1):37-63. doi: 10.1007/s12035-012-8337-y. Epub 2012 Sep 16.

Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Reddy PH.

Biochim Biophys Acta. 2013 Jan;1832(1):67-75. doi: 10.1016/j.bbadis.2012.09.003. Epub 2012 Sep 17.

Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue

Bruggink KA, Jongbloed W, Biemans EA, Veerhuis R, Claassen JA, Kuiperij HB, Verbeek MM.

Anal Biochem. 2013 Feb 15;433(2):112-20. doi: 10.1016/j.ab.2012.09.014. Epub 2012 Sep 26.

Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins

Maatuk N, Samson AO.

Neurotoxicology. 2013 Jan;34:236-42. doi: 10.1016/j.neuro.2012.09.007. Epub 2012 Sep 25.

Self-regulated music stimulation for persons with Alzheimer's disease: impact assessment and social validation

Lancioni GE, Singh NN, O'Reilly MF, Green VA, Ferlisi G, Ferrarese G, Zullo V, Perilli V, Cassano G, Cordiano N, Pinto K, Zonno N.

Dev Neurorehabil. 2013;16(1):17-26. doi: 10.3109/17518423.2012.707693. Epub 2012 Oct 3.

Na⁺-K⁺-ATPase, a potent neuroprotective modulator against Alzheimer disease

Zhang LN, Sun YJ, Pan S, Li JX, Qu YE, Li Y, Wang YL, Gao ZB.

Fundam Clin Pharmacol. 2013 Feb;27(1):96-103. doi: 10.1111/fcp.12000. Epub 2012 Oct 3.

Axonal transport and mitochondrial dysfunction in Alzheimer's disease

Riemer J, Kins S.

Neurodegener Dis. 2013;12(3):111-24. doi: 10.1159/000342020. Epub 2012 Sep 28.

Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease

Babiloni C, Infarinato F, Aujard F, Bastlund JF, Bentivoglio M, Bertini G, Del Percio C, Fabene PF, Forloni G, Herrero Ezquerro MT, Noè FM, Pifferi F, Ros-Bernal F, Christensen DZ, Dix S, Richardson JC, Lamberty Y, Drinkenburg W, Rossini PM.

Clin Neurophysiol. 2013 Mar;124(3):437-51. doi: 10.1016/j.clinph.2012.07.023. Epub 2012 Oct 4.

Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain

Sultana R, Perluigi M, Butterfield DA.

Free Radic Biol Med. 2013 Sep;62:157-169. doi: 10.1016/j.freeradbiomed.2012.09.027. Epub 2012 Oct 5.

Oral reading fluency analysis in patients with Alzheimer disease and asymptomatic control subjects

Martínez-Sánchez F, Meilán JJ, García-Sevilla J, Carro J, Arana JM.

Neurologia. 2013 Jul-Aug;28(6):325-31. doi: 10.1016/j.nrl.2012.07.012. Epub 2012 Oct 6.

Non-coding RNAs in Alzheimer's disease

Tan L, Yu JT, Hu N, Tan L.

Mol Neurobiol. 2013 Feb;47(1):382-93. doi: 10.1007/s12035-012-8359-5. Epub 2012 Oct 7.

Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison

Franciotti R, Falasca NW, Bonanni L, Anzellotti F, Maruotti V, Comani S, Thomas A, Tartaro A, Taylor JP, Onofrj M.

Neurobiol Aging. 2013 Apr;34(4):1148-58. doi: 10.1016/j.neurobiolaging.2012.09.015. Epub 2012 Oct 11.

CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease

Li L, Yin Z, Liu J, Li G, Wang Y, Yan J, Zhou H.

J Neurol. 2013 Jul;260(7):1701-8. doi: 10.1007/s00415-012-6690-4. Epub 2012 Oct 16.

Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study

Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M.

J Neural Transm (Vienna). 2013 May;120(5):813-9. doi: 10.1007/s00702-012-0902-z. Epub 2012 Oct 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias